- Главная
- Бесплатная аналитика приложений
- Pinkypromise-Alnoor
- Pinkypromise-Alnoor Vs. Breast Cancer Survivorship
Pinkypromise-Alnoor против Breast Cancer Survivorship Использование & Stats
Simple app for Breast self examination to prevent Breast Cancer.
- Apple App Store
- Бесплатный
- Здоровье & Фитнес
Рейтинг магазина
- -
About Us
“Thrive HKU” is an initiative mobile application of The Department of Clinical Oncology, LKS Faculty of Medicine of the University of Hong Kong. “Thrive HKU” aims to provides better support for breast cancer survivors both physically and psychologically.
“Thrive HKU” equips breast cancer survivors with educational materials on breast cancer management and psychological support. Registered users will be given a Pink Fitbit which can encourage them to have more exercises and have a healthy lifestyle.
We wish breast cancer survivors who use the thrive app and Pink Fitbit every day can have a bright and healthy future!
Disclaimer
The information contained in this App is for general educational purpose and reference only. Such information is not medical advice, diagnosis or treatment on any individual case or patient and should not be treated as a substitute for professional medical advice, diagnosis or treatment. You should consult your attending doctor or health professional for any medical condition that you may have, rather than relying on the information provided in this App.
- Apple App Store
- Бесплатный
- Здоровье & Фитнес
Рейтинг магазина
- -
Pinkypromise-Alnoor vs. Breast Cancer Survivorship ranking comparison
Compare Pinkypromise-Alnoor ranking trend in the past 28 days vs. Breast Cancer Survivorship
Rank
Нет данных
Рейтинг Pinkypromise-Alnoor против Breast Cancer Survivorship в сравнении по странам
Сравните динамику рейтинга Pinkypromise-Alnoor за последние 28 дней с динамикой рейтинга Breast Cancer Survivorship.
Нет данных для отображения
Сравните данные с любым сайтом, воспользовавшись бесплатной пробной версией
Pinkypromise-Alnoor VS.
Breast Cancer Survivorship
декабрь 31, 2024